143 related articles for article (PubMed ID: 6200329)
1. Effects of sodium butyrate and dimethylsulfoxide on human pancreatic tumor cell lines.
McIntyre LJ; Kim YS
Eur J Cancer Clin Oncol; 1984 Feb; 20(2):265-71. PubMed ID: 6200329
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of sodium butyrate and dimethylsulfoxide on gamma-glutamyl transpeptidase and alkaline phosphatase activities in MCF-7 breast cancer cells.
Wasserman L; Nordenberg J; Beery E; Deutsch AA; Novogrodsky A
Exp Cell Biol; 1987; 55(4):188-93. PubMed ID: 2890541
[TBL] [Abstract][Full Text] [Related]
3. Effects of sodium butyrate and dimethylsulfoxide on biochemical properties of human colon cancer cells.
Kim YS; Tsao D; Siddiqui B; Whitehead JS; Arnstein P; Bennett J; Hicks J
Cancer; 1980 Mar; 45(5 Suppl):1185-92. PubMed ID: 7357511
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of sodium butyrate, dimethyl sulfoxide, and retinoic acid on membrane-associated antigen, enzymes, and glycoproteins of human rectal adenocarcinoma cells.
Tsao D; Morita A; Bella A; Luu P; Kim YS
Cancer Res; 1982 Mar; 42(3):1052-8. PubMed ID: 7059970
[TBL] [Abstract][Full Text] [Related]
5. Trypsinogen expression by two human pancreatic cell lines CFPAC-1 and CAPAN-1. Modulation during spontaneous and induced cell growth.
Miszczuk-Jamska B; Merten M; Renaud W; Guy-Crotte O; Figarella C
Int J Pancreatol; 1994 Aug; 16(1):61-9. PubMed ID: 7806913
[TBL] [Abstract][Full Text] [Related]
6. Differentiation inducing effects of butyrate and DMSO on human intestinal tumor cell lines in culture.
Joshi SS; Jackson JD; Sharp JG
Cancer Detect Prev; 1985; 8(1-2):237-45. PubMed ID: 4064044
[TBL] [Abstract][Full Text] [Related]
7. Ultrastructural differentiation of sodium butyrate-treated human pancreatic adenocarcinoma cell lines.
Mullins TD; Kern HF; Metzgar RS
Pancreas; 1991 Sep; 6(5):578-87. PubMed ID: 1946315
[TBL] [Abstract][Full Text] [Related]
8. In vitro phenotypic alteration of human melanoma cells induced by differentiating agents: heterogeneous effects on cellular growth and morphology, enzymatic activity, and antigenic expression.
Takahashi H; Parsons PG
Pigment Cell Res; 1990 Nov; 3(5):223-32. PubMed ID: 1710361
[TBL] [Abstract][Full Text] [Related]
9. Effect of sodium butyrate, a differentiating agent, on cell surface glycoconjugates of a human pancreatic cell line.
Bloom EJ; Siddiqui B; Hicks JW; Kim YS
Pancreas; 1989; 4(1):59-64. PubMed ID: 2717602
[TBL] [Abstract][Full Text] [Related]
10. Modulation of EGF receptor expression by differentiating agents in human colon carcinoma cell lines.
Murphy LD; Valverius EM; Tsokos M; Mickley LA; Rosen N; Bates SE
Cancer Commun; 1990; 2(10):345-55. PubMed ID: 2206777
[TBL] [Abstract][Full Text] [Related]
11. The expression of the myc proto-oncogene in a dimethylsulfoxide resistant HL-60 cell line.
Grosso LE; Pitot HC
Cancer Lett; 1984 Feb; 22(1):55-63. PubMed ID: 6583000
[TBL] [Abstract][Full Text] [Related]
12. Effect of dimethylsulfoxide and butyrate on 5'-nucleotidase of human renal carcinoma cells.
Prager MD; Kanar MC
Cancer Lett; 1984 Aug; 24(1):81-8. PubMed ID: 6093992
[TBL] [Abstract][Full Text] [Related]
13. The effect of sodium butyrate and retinoic acid on growth and CEA production in a series of human colorectal tumor cell lines representing different states of differentiation.
Niles RM; Wilhelm SA; Thomas P; Zamcheck N
Cancer Invest; 1988; 6(1):39-45. PubMed ID: 3365571
[TBL] [Abstract][Full Text] [Related]
14. Modulation of secreted plasminogen activator activity of human renal carcinoma cells by dimethylsulfoxide, butyrate and retinoate.
Nelson NF; Cieplak W; Dacus SC; Prager MD
Cancer Lett; 1987 Mar; 34(3):305-16. PubMed ID: 3548947
[TBL] [Abstract][Full Text] [Related]
15. Alteration of melanoma melanogenesis by phenotypic modifiers.
Takahashi H; Horikoshi T; Wakamatsu K; Ito S; Parsons PG
J Dermatol; 1992 Nov; 19(11):814-7. PubMed ID: 1363429
[TBL] [Abstract][Full Text] [Related]
16. Effect of sodium butyrate and other differentiation inducers on poorly differentiated human ovarian adenocarcinoma cell lines.
Langdon SP; Hawkes MM; Hay FG; Lawrie SS; Schol DJ; Hilgers J; Leonard RC; Smyth JF
Cancer Res; 1988 Nov; 48(21):6161-5. PubMed ID: 3167862
[TBL] [Abstract][Full Text] [Related]
17. Characterization of differentiation-inducer-resistant HL-60 cells.
Gallagher RE; Bilello PA; Ferrari AC; Chang CS; Yen RW; Nickols WA; Muly EC
Leuk Res; 1985; 9(8):967-86. PubMed ID: 3862924
[TBL] [Abstract][Full Text] [Related]
18. Ultrastructural differentiation and CEA expression of butyrate-treated human pancreatic carcinoma cells.
el-Deriny SE; O'Brien MJ; Christensen TG; Kupchik HZ
Pancreas; 1987; 2(1):25-33. PubMed ID: 3575313
[TBL] [Abstract][Full Text] [Related]
19. Growth inhibition of murine melanoma by butyric acid and dimethylsulfoxide.
Nordenberg J; Wasserman L; Beery E; Aloni D; Malik H; Stenzel KH; Novogrodsky A
Exp Cell Res; 1986 Jan; 162(1):77-85. PubMed ID: 3079593
[TBL] [Abstract][Full Text] [Related]
20. Combinations of retinoic acid with either sodium butyrate, dimethyl sulfoxide, or hexamethylene bisacetamide synergistically induce differentiation of the human myeloid leukemia cell line HL60.
Breitman TR; He RY
Cancer Res; 1990 Oct; 50(19):6268-73. PubMed ID: 2400989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
